Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death Due to Disease in High Risk Non-Metastatic Melanoma

類似資料

• Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment()
  著者:: Cassidy, Michael R., 等
  出版事項: (2017)
• High Neutrophil to Lymphocyte Ratio (NLR) is Associated with Treatment Failure and Death in Melanoma Patients Treated with PD-1 Inhibitor Monotherapy
  著者:: Bartlett, Edmund K., 等
  出版事項: (2019)
• A peripheral blood biomarker estimates probability of survival: the neutrophil–lymphocyte ratio in noncancer patients
  著者:: Davis, Jeremy L, 等
  出版事項: (2016)
• Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
  著者:: Ferrucci, P F, 等
  出版事項: (2015)
• Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome
  著者:: Kurtul, B E, 等
  出版事項: (2016)